Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 131, Issue 12
March 22 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

MYELOID NEOPLASIA
Consensus on MRD in AML?
Elisabeth Paietta
View Articletitled, Consensus on MRD in AML?
CLINICAL TRIALS AND OBSERVATIONS
Woody eyes, be gone!
Clinical Trials & Observations
Trisha E. Wong
View Articletitled, Woody eyes, be gone!
Hematopoiesis and Stem Cells
Set(d1a)-ing novel links between HSC regulators
Isabel Beerman
View Articletitled, Set(d1a)-ing novel links between HSC regulators
Lymphoid Neoplasia
There is nothing minimal about residual disease
Jerald P. Radich
View Articletitled, There is nothing minimal about residual disease
THROMBOSIS AND HEMOSTASIS
Treating hemophilia by targeting protein S?
Björn Dahlbäck
View Articletitled, Treating hemophilia by targeting protein S?
TRANSPLANTATION
HSCT for GATA2 deficiency across the pond
Dennis Hickstein
View Articletitled, HSCT for GATA2 deficiency across the pond

SPECIAL REPORT

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Clinical Trials & Observations
Gerrit J. Schuurhuis,Michael Heuser,Sylvie Freeman,Marie-Christine Béné,Francesco Buccisano,Jacqueline Cloos,David Grimwade,Torsten Haferlach,Robert K. Hills,Christopher S. Hourigan,Jeffrey L. Jorgensen,Wolfgang Kern,Francis Lacombe,Luca Maurillo,Claude Preudhomme,Bert A. van der Reijden,Christian Thiede,Adriano Venditti,Paresh Vyas,Brent L. Wood,Roland B. Walter,Konstanze Döhner,Gail J. Roboz,Gert J. Ossenkoppele
View Articletitled, Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Supplemental data

HOW I TREAT

How I treat type 2B von Willebrand disease
Rebecca Kruse-Jarres,Jill M. Johnsen
View Articletitled, How I treat type 2B von Willebrand disease

CLINICAL TRIALS AND OBSERVATIONS

Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
Clinical Trials & Observations
Amy D. Shapiro,Charles Nakar,Joseph M. Parker,Gary R. Albert,John E. Moran,Karen Thibaudeau,Neelam Thukral,Brandon M. Hardesty,Pierre Laurin,Per Morten Sandset
View Articletitled, Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
Supplemental data

HEMATOPOIESIS AND STEM CELLS

SETD1A protects HSCs from activation-induced functional decline in vivo
Kathrin Arndt,Andrea Kranz,Juliane Fohgrub,Adrien Jolly,Anita S. Bledau,Michela Di Virgilio,Mathias Lesche,Andreas Dahl,Thomas Höfer,A. Francis Stewart,Claudia Waskow
View Articletitled, SETD1A protects HSCs from activation-induced functional decline in vivo
Supplemental data

LYMPHOID NEOPLASIA

Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin
Wei Jiang,Xiaoyan Zhou,Zengxia Li,Kaiyu Liu,Weige Wang,Renke Tan,Xiaoji Cong,Jiaoyu Shan,Yanxia Zhan,Zhaomeng Cui,Lizhi Jiang,Quanfu Li,Suqin Shen,Meirong Bai,Yunfeng Cheng,Bin Li,Minjia Tan,Dengke K. Ma,Jun O. Liu,Yongjun Dang
View Articletitled, Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin
Supplemental data
Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia
Julia C. Gutjahr,Eva Szenes,Lisa Tschech,Daniela Asslaber,Michaela Schlederer,Simone Roos,Xiaobing Yu,Tamara Girbl,Christina Sternberg,Alexander Egle,Fritz Aberger,Ronen Alon,Lukas Kenner,Richard Greil,Veronique Orian-Rousseau,Tanja N. Hartmann
View Articletitled, Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia
Supplemental data
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
Clinical Trials & Observations
Brent Wood,David Wu,Beryl Crossley,Yunfeng Dai,David Williamson,Charles Gawad,Michael J. Borowitz,Meenakshi Devidas,Kelly W. Maloney,Eric Larsen,Naomi Winick,Elizabeth Raetz,William L. Carroll,Stephen P. Hunger,Mignon L. Loh,Harlan Robins,Ilan Kirsch
View Articletitled, Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
Supplemental data

THROMBOSIS AND HEMOSTASIS

Targeting anticoagulant protein S to improve hemostasis in hemophilia
Raja Prince,Luca Bologna,Mirko Manetti,Daniela Melchiorre,Irene Rosa,Natacha Dewarrat,Silvia Suardi,Poorya Amini,José A. Fernández,Laurent Burnier,Claudia Quarroz,Maria Desiré Reina Caro,Yasuhiro Matsumura,Johanna A. Kremer Hovinga,John H. Griffin,Hans-Uwe Simon,Lidia Ibba-Manneschi,François Saller,Sara Calzavarini,Anne Angelillo-Scherrer
View Articletitled, Targeting anticoagulant protein S to improve hemostasis in hemophilia
Supplemental data

TRANSPLANTATION

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
Clinical Trials & Observations
John M. Magenau,Steven C. Goldstein,Dan Peltier,Robert J. Soiffer,Thomas Braun,Attaphol Pawarode,Mary M. Riwes,Maggi Kennel,Joseph H. Antin,Corey S. Cutler,Vincent T. Ho,Edwin P. Alyea, III,Brian L. Parkin,Gregory A. Yanik,Sung Won Choi,Eli C. Lewis,Charles A. Dinarello,John Koreth,Pavan Reddy
View Articletitled, α<sub>1</sub>-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
Supplemental data

LETTERS TO BLOOD

Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands
Clinical Trials & Observations
Avinash G. Dinmohamed,Eduardus F. M. Posthuma,Otto Visser,Arnon P. Kater,Reinier A. P. Raymakers,Jeanette K. Doorduijn
View Articletitled, Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands
Supplemental data
In vivo T-depleted reduced-intensity transplantation for GATA2-related immune dysfunction
Eleni Tholouli,Katherine Sturgess,Rachel E. Dickinson,Andrew Gennery,Andrew J. Cant,Graham Jackson,Jim Lordan,Sophie Hambleton,Mary A. Slatter,Venetia Bigley,Matthew Collin
View Articletitled, In vivo T-depleted reduced-intensity transplantation for <em>GATA2</em>-related immune dysfunction
Supplemental data

BLOOD WORK

Severe acute anemia attributable to concomitant occurrence of AIHA with PRCA induced by parvovirus B19 infection
Christelle El Khoury,Hussein Farhat
View Articletitled, Severe acute anemia attributable to concomitant occurrence of AIHA with PRCA induced by parvovirus B19 infection
Differential diagnosis of myelodysplastic syndrome: anemia associated with copper deficiency
Ana Villalba,Leonor Senent
View Articletitled, Differential diagnosis of myelodysplastic syndrome: anemia associated with copper deficiency

ERRATUM

Blatt K, Cerny-Reiterer S, Schwaab J, et al. Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis. Blood. 2015;126(26):2832-2841.
View Articletitled, Blatt K, Cerny-Reiterer S, Schwaab J, et al. Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis. <em>Blood.</em> 2015;126(26):2832-2841.
All Issues

Advertisement intended for health care professionals

TR4 and BCL11A Repress γ-globin Transcription via Independent Mechanisms
How I Treat Older Patients with Ph/BCR-ABL-Negative Acute Lymphoblastic Leukemia
T-Cell Lymphomas in Recipients of CAR-T Cells: Assessing Risks and Causalities
Constitutive STAT5 activation in precursor B-cell acute lymphoblastic leukemia with P2RY8::CRLF2 fusion
Genetic alteration of class I HLA in cutaneous T-cell lymphoma

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals